EGFR and neoplasm: In the comparison of tumour recurrence rates, we found a higher recurrence rate in the experimental group (66.00%) than in the control group (40.91%), with a statistically significant difference between the two groups (χ2 = 5.937, P=0.015), suggesting that our patients with amplified EGFR genes were more prone to recurrence and metastasis.